UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$745M |
| 2 |
Spotify
SPOT
|
+$727M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$689M |
| 4 |
Meta Platforms (Facebook)
META
|
+$680M |
| 5 |
NXP Semiconductors
NXPI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$1.33B |
| 2 |
Union Pacific
UNP
|
+$1.2B |
| 3 |
Equinix
EQIX
|
+$929M |
| 4 |
Broadcom
AVGO
|
+$805M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.43% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Kingsway Corp
KWY
$277M
| $4.96K | ﹤0.01% |
+369
| New | +$5.06K |
2025 Q4
0 quarters
|
|
2977
Zevra Therapeutics
ZVRA
$590M
| $4.93K | ﹤0.01% |
+550
| New | +$5.2K |
2025 Q4
0 quarters
|
|
2978
Financial Institutions
FISI
$775M
| $4.89K | ﹤0.01% |
+157
| New | +$4.63K |
2025 Q4
0 quarters
|
|
2979
IBEX
IBEX
$606M
| $4.89K | ﹤0.01% |
+128
| New | +$4.73K |
2025 Q4
0 quarters
|
|
|
MRX
2980
Marex Group Limited Ordinary Shares
MRX
$5.07B
| $4.87K | ﹤0.01% |
+127
| New | +$4.32K |
2025 Q4
0 quarters
|
|
2981
Avantis International Equity ETF
AVDE
$19.2B
| $4.86K | ﹤0.01% |
+59
| New | +$4.73K |
2025 Q4
0 quarters
|
|
2982
Nu Skin
NUS
$250M
| $4.84K | ﹤0.01% |
+503
| New | +$5.2K |
2025 Q4
0 quarters
|
|
2983
MeiraGTx Holdings
MGTX
$891M
| $4.83K | ﹤0.01% |
+607
| New | +$5.05K |
2025 Q4
0 quarters
|
|
2984
Verastem
VSTM
$783M
| $4.81K | ﹤0.01% |
+623
| New | +$5.55K |
2025 Q4
0 quarters
|
|
2985
abrdn Healthcare Opportunities Fund
THQ
$743M
| $4.78K | ﹤0.01% |
+250
| New | +$4.59K |
2025 Q4
0 quarters
|
|
2986
Keros Therapeutics
KROS
$211M
| $4.76K | ﹤0.01% |
+234
| New | +$4.11K |
2025 Q4
0 quarters
|
|
2987
DELISTED
Blue Foundry Bancorp
BLFY
| $4.74K | ﹤0.01% |
+381
| New | +$3.8K |
2025 Q4
0 quarters
|
|
2988
Alerian MLP ETF
AMLP
$12.7B
| $4.7K | ﹤0.01% |
+100
| New | +$4.68K |
2025 Q4
0 quarters
|
|
2989
Mativ Holdings
MATV
$619M
| $4.63K | ﹤0.01% |
+381
| New | +$4.49K |
2025 Q4
0 quarters
|
|
2990
Aldeyra Therapeutics
ALDX
$42.2M
| $4.62K | ﹤0.01% |
+892
| New | +$4.58K |
2025 Q4
0 quarters
|
|
2991
Citi Trends
CTRN
$406M
| $4.61K | ﹤0.01% |
+111
| New | +$4.38K |
2025 Q4
0 quarters
|
|
2992
Lands' End
LE
$291M
| $4.52K | ﹤0.01% |
+311
| New | +$4.8K |
2025 Q4
0 quarters
|
|
2993
Genie Energy
GNE
$439M
| $4.49K | ﹤0.01% |
+326
| New | +$4.8K |
2025 Q4
0 quarters
|
|
2994
Invesco S&P 500 Pure Growth ETF
RPG
$1.79B
| $4.48K | ﹤0.01% |
+96
| New | +$4.5K |
2025 Q4
0 quarters
|
|
2995
Plains All American Pipeline
PAA
$17.8B
| $4.44K | ﹤0.01% |
+247
| New | +$4.2K |
2025 Q4
0 quarters
|
|
2996
Norwood Financial Corp
NWFL
$366M
| $4.43K | ﹤0.01% |
+158
| New | +$4.31K |
2025 Q4
0 quarters
|
|
2997
Caleres
CAL
$448M
| $4.43K | ﹤0.01% |
364
-78,757
| -100% | -$969K |
2021 Q1
19 quarters
|
|
2998
Eagle Financial Services Inc
EFSI
$248M
| $4.34K | ﹤0.01% |
+109
| New | +$4.08K |
2025 Q4
0 quarters
|
|
2999
Plumas Bancorp
PLBC
$432M
| $4.33K | ﹤0.01% |
+97
| New | +$4.16K |
2025 Q4
0 quarters
|
|
3000
Empire State Realty Trust
ESRT
$800M
| $4.32K | ﹤0.01% |
663
-1,054,590
| -100% | -$7.53M |
2013 Q4
48 quarters
|
|
Similar funds
UBS AM's Q4 2025 Portfolio in Review
As of Q4 2025, UBS AM held 3,345 positions worth $473B, up 2.7% from $461B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS AM's Q4 2025 filing shows 1,074 new, 1,062 increased, 1,120 reduced and 60 closed positions. Its largest new stake was Chubb: 2,548,307 shares worth $795M. The largest sale was Prologis, an estimated $1.33B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2025 buy was Chubb: 2,548,307 shares worth $795M.
- UBS AM added most to Spotify in Q4 2025, an estimated $727M increase.
- UBS AM's biggest Q4 2025 reduction was Prologis, cutting an estimated $1.33B.
- UBS AM fully exited Kellanova in Q4 2025, selling an estimated $211M.
- UBS AM's ten largest holdings make up 36% of its $473B portfolio in Q4 2025.
- UBS AM opened 1,074 new positions and closed 60 in Q4 2025.
- UBS AM's portfolio value rose 2.7% quarter-over-quarter to $473B.
Based on UBS AM's 13F filing for Q4 2025, filed 13 Feb 2026.